ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their price targets and ratings for several US-listed companies, including Tarsus Pharmaceuticals, Apellis Pharmaceuticals, Axon Enterprise, Essex Property Trust, Integral Ad Science Holding Corp, Sterling Infrastructure, LendingTree, ICU Medical, Ecolab, and Abercrombie & Fitch. These changes reflect analysts' latest views on these companies, with adjustments made based on various factors such as company performance and market conditions.
February 28, 2024 | 1:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Telsey Advisory Group raised Abercrombie & Fitch's price target from $105 to $140, maintaining an Outperform rating.
The significant increase in ANF's price target, along with an Outperform rating, suggests strong analyst confidence and a positive outlook, likely leading to short-term price appreciation.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Needham raised Axon Enterprise's price target from $240 to $315, reiterating a Buy rating.
The significant increase in AXON's price target, coupled with a Buy rating, suggests strong analyst confidence in the company's future performance, potentially leading to positive short-term price momentum.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Barclays upgraded Ecolab from Equal-Weight to Overweight, raising the price target from $225 to $260.
The upgrade to Overweight and the increased price target indicate a strong positive shift in analyst sentiment towards ECL, likely leading to increased investor interest and short-term price appreciation.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Mizuho upgraded Essex Property Trust from Neutral to Buy, adjusting the price target from $255 to $250.
The upgrade to a Buy rating indicates a positive shift in analyst sentiment towards ESS, despite a slight decrease in the price target. This could lead to increased investor interest and a short-term price rise.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Keybanc modestly increased ICU Medical's price target from $134 to $136, with an Overweight rating.
The slight increase in ICUI's price target, coupled with an Overweight rating, suggests a positive but cautious outlook, potentially leading to modest short-term price growth.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Oppenheimer raised the price target for Tarsus Pharmaceuticals from $55 to $59, maintaining an Outperform rating.
The increase in price target by a reputable analyst firm suggests a positive outlook on TARS, likely leading to increased investor confidence and a potential short-term price increase.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Needham increased LendingTree's price target from $17 to $40, maintaining a Buy rating.
The substantial increase in TREE's price target, along with a Buy rating, indicates strong analyst confidence and a positive outlook, likely leading to short-term price appreciation.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEUTRAL IMPACT
Wedbush increased the price target for Apellis Pharmaceuticals from $60 to $67, with a Neutral rating.
The price target increase for APLS, despite a Neutral rating, indicates a cautious optimism. The neutral stance suggests limited short-term price movement.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Raymond James downgraded Integral Ad Science from Strong Buy to Outperform, lowering the price target from $20 to $16.
The downgrade, despite remaining positive, and the reduced price target may create uncertainty among investors, potentially leading to neutral short-term price movement.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
DA Davidson raised Sterling Infrastructure's price target from $86 to $115 but downgraded the stock to Neutral.
The significant increase in price target suggests a positive view on STRL's value, but the downgrade to Neutral indicates a cautious stance on short-term price movement.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85